Guest guest Posted June 21, 2009 Report Share Posted June 21, 2009 In my lab today Phil Moheno and I completed the world's largest supply of calcium pterin. Phil has the US patent on this. We made CaPterin as an IDO inhibitor to help unmask cancer cells such that they could no longer defy immune surveillance. It is essentially a natural product related to folic acid, but I suspect it might well end up on a shelf. The subsequent conversation revolved about the potential of liability and all the steps necessary to avoid legal pitfalls. I may have 2 or 3 dozen excellent cancer treatments that just sit around collecting dust because of a lack of funds to develop them and fear of liability if we don't salute all the controlling authorities. If this is true for me then I suspect that there are thousands and thousands of similar novel meds/supplements sitting around in other labs. This must be so. I'm sure that I could wallpaper a subway station with all the non-disclosures that I have signed. I suspect that Phil will want to develop DCP (dipterinyl calcium pentahydrate) and go through the usual FDA channels. It will be years before it is approved if ever. It is sad. Cancer patients are constantly informed of the wonderful products in development, but the approvals just never seem to come. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.